| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2f3d0976241d3390cbfc886c6f065387
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2224bdf8895e3f95cb634727debe16bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2817954cd008bcd609a4c4eb49050be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6ed99e23014f4e33c9b8c5f39c1c4682
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12a5064a167bad048f3fa7ce230836fd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2217-05 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-19
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-395 |
| filingDate |
2003-07-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_54c7560f4d8cf701fcc86b6f8c038a53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f97b8feadb074ae41025e384bdaddcd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1dd3e673849b41b89d9dd79040042c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d74bde6b45d6522a63da16a148c5b27 |
| publicationDate |
2004-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004007719-A1 |
| titleOfInvention |
Use of sumo- and ubiquitin-modified pcna for detection and channeling of dna transaction pathways |
| abstract |
The invention concerns the use and detection of SUMOylated and/or ubiquitylated PCNA for the detection and channelling of DNA transaction pathways within cells and cell-like systems. The invention also concerns antibodies that specifically recognise differentially SUMOylated and/or ubiquitylated forms of PCNA. Moreover, the invention concerns screening methods for the isolation of compounds that can be used to selectively enhance or suppress DNA transaction activities of cells and cell-like systems. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7612606-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7714563-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7880533-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7576598-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8102201-B2 |
| priorityDate |
2002-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |